Welcome to the National Cancer Institute’s Minority and Underserved Community Oncology Research Program (MU-NCORP) at The Herbert Irving Comprehensive Cancer Center in Washington Heights.
The purpose of the program is to offer local residents state-of-the-art cancer prevention and access to the latest clinical trials at Columbia University Medical Center and NewYork-Presbyterian Hospital in uptown Manhattan.
The NCI’s NCORP is part of a $93 million initiative launched in August 2014 by the National Institutes of Health to ensure that all population groups are represented in cancer research. The NCORP network includes many urban and rural hospitals; however, Columbia University Medical Center is one of only 12 Minority and Underserved NCORPs.
What does this mean for patients?
Columbia University Medical Center has long been committed to improving healthcare access for area residents. Our neighborhood is 71 percent Hispanic and 14 percent black, with nearly one-third living below the poverty level. Cancer is the leading cause of reduced lifespan for members of this community.
Our clinical trials allow patients to take advantage of the latest and most advanced cancer treatments while staying close to family, friends, support systems, local physicians and health organizations
Those who participate in high quality clinical studies receive ongoing monitoring and better healthcare. Our patients benefit from the combined expertise of a national network of cancer researchers throughout the US and in Puerto Rico, and from internationally known physicians at the Herbert Irving Cancer Center—one of the nation’s most prestigious cancer institutes.